Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 139.31
+4.31 (3.19%)
Jun 30, 2025, 2:45 PM CST
Beijing Hotgen Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -220.07 | -191 | 28.92 | 944.74 | 2,186 | 112.07 | Upgrade
|
Depreciation & Amortization | 89.05 | 89.05 | 70.53 | 120.29 | 68.34 | 29.15 | Upgrade
|
Other Amortization | 15.77 | 15.77 | 7.76 | 28.15 | 5.38 | 10.94 | Upgrade
|
Loss (Gain) From Sale of Assets | 1.63 | 1.63 | 0.64 | 0.34 | 14.21 | 0.18 | Upgrade
|
Asset Writedown & Restructuring Costs | 55.15 | 55.15 | 36.95 | 70.06 | 8.51 | 0.14 | Upgrade
|
Loss (Gain) From Sale of Investments | 9.36 | 9.36 | 23.68 | -10.91 | -24.88 | -8.13 | Upgrade
|
Provision & Write-off of Bad Debts | 1.36 | 1.36 | -13.4 | 11.34 | 0.7 | 1.2 | Upgrade
|
Other Operating Activities | 57.6 | 24.39 | -59.57 | 94.17 | 118.58 | -2.02 | Upgrade
|
Change in Accounts Receivable | -77.16 | -77.16 | 93.75 | -22.28 | -81.52 | -19.87 | Upgrade
|
Change in Inventory | 47.59 | 47.59 | 123.21 | 36.03 | -213.43 | -60.14 | Upgrade
|
Change in Accounts Payable | 3.31 | 3.31 | -284.98 | -242.99 | 564.77 | 97.55 | Upgrade
|
Change in Other Net Operating Assets | -24.34 | -24.34 | -71.27 | -32.27 | 8.46 | 4.3 | Upgrade
|
Operating Cash Flow | -33.01 | -37.16 | -48.53 | 978.75 | 2,644 | 164.62 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -62.99% | 1506.38% | 749.79% | Upgrade
|
Capital Expenditures | -14.48 | -51.41 | -413.37 | -565.21 | -398.86 | -172.27 | Upgrade
|
Sale of Property, Plant & Equipment | 1.19 | 1.19 | 3.74 | 0.58 | 0.13 | 0.05 | Upgrade
|
Divestitures | -7.89 | -7.89 | -17.11 | -0.08 | - | - | Upgrade
|
Investment in Securities | -84.4 | 130.21 | 238.61 | -602.42 | -1,367 | - | Upgrade
|
Other Investing Activities | 92.95 | 38.74 | 26.56 | 17.08 | 22.34 | 8.13 | Upgrade
|
Investing Cash Flow | -12.64 | 110.83 | -161.57 | -1,130 | -1,763 | -164.1 | Upgrade
|
Total Debt Issued | 50 | - | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
Total Debt Repaid | -5.12 | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
Net Debt Issued (Repaid) | 44.88 | -5.12 | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
Issuance of Common Stock | 44.02 | 45.02 | 3.34 | - | - | - | Upgrade
|
Repurchase of Common Stock | -92.03 | -92.03 | -16.44 | -150.04 | - | - | Upgrade
|
Common Dividends Paid | -17.58 | -17.34 | - | -310.98 | -93.29 | -19.1 | Upgrade
|
Other Financing Activities | 6.53 | -10 | 3.8 | 8.32 | 9.63 | 0.69 | Upgrade
|
Financing Cash Flow | -14.18 | -79.48 | -36.55 | -484.99 | -95.07 | -42.16 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.65 | -0.15 | -0.46 | 5.2 | -14.83 | 1.4 | Upgrade
|
Net Cash Flow | -59.18 | -5.96 | -247.11 | -631.09 | 771.69 | -40.23 | Upgrade
|
Free Cash Flow | -47.5 | -88.57 | -461.9 | 413.54 | 2,246 | -7.65 | Upgrade
|
Free Cash Flow Growth | - | - | - | -81.58% | - | - | Upgrade
|
Free Cash Flow Margin | -9.73% | -17.34% | -84.31% | 11.63% | 41.82% | -1.49% | Upgrade
|
Free Cash Flow Per Share | -0.50 | -0.96 | -5.23 | 4.50 | 24.40 | -0.08 | Upgrade
|
Cash Income Tax Paid | 4.35 | 8.39 | 20.06 | 371.82 | 312.86 | 0.66 | Upgrade
|
Levered Free Cash Flow | -410.21 | 36.2 | -561.63 | 129.6 | 1,644 | -35.57 | Upgrade
|
Unlevered Free Cash Flow | -409.93 | 36.48 | -561 | 131.05 | 1,645 | -35.29 | Upgrade
|
Change in Net Working Capital | 396.3 | -69.39 | 201.45 | 143.77 | -353.02 | -22.32 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.